We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Role of the combination of FA and T2* parameters as a new diagnostic method in therapeutic evaluation of parkinson's disease.
- Authors
Fang, Yuan; Zheng, Tao; Liu, Lanxiang; Gao, Dawei; Shi, Qinglei; Dong, Yanchao; Du, Dan
- Abstract
<bold>Background: </bold>Simple diffusion delivery (SDD) has attained good effects with only tiny amounts of drugs. Fractional anisotropy (FA) and relaxation time T2* that indicate the integrity of fiber tracts and iron concentration within brain tissue were used to evaluate the therapeutic effect of SDD.<bold>Purpose: </bold>To evaluate therapeutic effect of SDD in the Parkinson's disease (PD) rat model with FA and T2* parameters.<bold>Study Type: </bold>Prospective case-control animal study.<bold>Population: </bold>Thirty-two male Sprague Dawley rats (eight normal, eight PD, eight SDD, and eight subcutaneous injection rats).<bold>Field Strength/sequence: </bold>Single-shot spin echo echo-planar imaging and fast low-angle shot T2 WI sequences at 3.0T.<bold>Assessment: </bold>Parameters of FA and T2* on the treated side of the substantia nigra were measured to evaluate the therapeutic effect of SDD in a PD rat model.<bold>Statistical Tests: </bold>The effects of time on FA and T2* values were analyzed by repeated measurement tests. A one-way analysis of variance was conducted, followed by individual comparisons of the mean FA and T2* values at different timepoints.<bold>Results: </bold>The FA values on the treated side of the substantia nigra in the SDD treatment group and subcutaneous injection treatment group were significantly higher at week 1 and lower at week 6 than that of the PD control group (SDD vs. PD, week 1, adjusted P = 0.012; subcutaneous vs. PD, week 1, adjusted P < 0.001; SDD vs. PD, week 6, adjusted P = 0.004; subcutaneous vs. PD, week 6, adjusted P = 0.024). The T2* parameter in the SDD treatment group and subcutaneous injection treatment group was significantly higher than that in the PD control group at week 6 (SDD vs. PD, adjusted P = 0.032; subcutaneous vs. PD, adjusted P < 0.001).<bold>Data Conclusion: </bold>The combination of FA and T2* parameters can potentially serve as a new effective evaluation method of the therapeutic effect of SDD.<bold>Level Of Evidence: </bold>1 Technical Efficacy: Stage 4 J. Magn. Reson. Imaging 2017.
- Publication
Journal of Magnetic Resonance Imaging, 2018, Vol 48, Issue 1, p84
- ISSN
1053-1807
- Publication type
journal article
- DOI
10.1002/jmri.25900